Cornerstone Investment Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,240
| Closed | -$518K | – | 294 |
|
|
2021
Q3 | $518K | Sell |
2,240
-7,830
| -78% | -$1.93M | 0.03% | 64 |
|
|
2021
Q2 | $2.31M | Sell |
10,070
-325
| -3% | -$65.3K | 0.12% | 40 |
|
|
2021
Q1 | $1.94M | Sell |
10,395
-395
| -4% | -$77.3K | 0.1% | 44 |
|
|
2020
Q4 | $1.82M | Hold |
10,790
| – | – | 0.11% | 42 |
|
|
2020
Q3 | $1.6M | Hold |
10,790
| – | – | 0.11% | 46 |
|
|
2020
Q2 | $1.77M | Hold |
10,790
| – | – | 0.13% | 45 |
|
|
2020
Q1 | $1.5M | Hold |
10,790
| – | – | 0.1% | 47 |
|
|
2019
Q4 | $1.42M | Hold |
10,790
| – | – | 0.07% | 53 |
|
|
2019
Q3 | $1.21M | Hold |
10,790
| – | – | 0.05% | 52 |
|
|
2019
Q2 | $1.2M | Hold |
10,790
| – | – | 0.05% | 53 |
|
|
2019
Q1 | $1.4M | Sell |
10,790
-2,100
| -16% | -$255K | 0.06% | 48 |
|
|
2018
Q4 | $1.49M | Hold |
12,890
| – | – | 0.07% | 43 |
|
|
2018
Q3 | $1.38M | Hold |
12,890
| – | – | 0.06% | 46 |
|
|
2018
Q2 | $1.1M | Hold |
12,890
| – | – | 0.05% | 51 |
|
|
2018
Q1 | $997K | Sell |
12,890
-749
| -5% | -$60.3K | 0.04% | 55 |
|
|
2017
Q4 | $1.15M | Hold |
13,639
| – | – | 0.05% | 53 |
|
|
2017
Q3 | $1.17M | Sell |
13,639
-160
| -1% | -$13.1K | 0.05% | 46 |
|
|
2017
Q2 | $1.14M | Sell |
13,799
-460
| -3% | -$37.5K | 0.05% | 48 |
|
|
2017
Q1 | $1.2M | Sell |
14,259
-332
| -2% | -$26.6K | 0.05% | 44 |
|
|
2016
Q4 | $1.07M | Buy |
14,591
+447
| +3% | +$33.3K | 0.04% | 50 |
|
|
2016
Q3 | $1.14M | Hold |
14,144
| – | – | 0.05% | 46 |
|
|
2016
Q2 | $1.11M | Hold |
14,144
| – | – | 0.04% | 45 |
|
|
2016
Q1 | $1.02M | Hold |
14,144
| – | – | 0.03% | 53 |
|
|
2015
Q4 | $1.19M | Hold |
14,144
| – | – | 0.04% | 50 |
|
|
2015
Q3 | $1.18M | Sell |
14,144
-3,415
| -19% | -$288K | 0.03% | 48 |
|
|
2015
Q2 | $1.47M | Sell |
17,559
-4,020
| -19% | -$306K | 0.03% | 44 |
|
|
2015
Q1 | $1.57M | Sell |
21,579
-901
| -4% | -$64.1K | 0.03% | 44 |
|
|
2014
Q4 | $1.55M | Sell |
22,480
-65
| -0.3% | -$4.39K | 0.02% | 44 |
|
|
2014
Q3 | $1.46M | Hold |
22,545
| – | – | 0.02% | 43 |
|
|
2014
Q2 | $1.4M | Sell |
22,545
-2,935
| -12% | -$175K | 0.02% | 43 |
|
|
2014
Q1 | $1.5M | Sell |
25,480
-4,710
| -16% | -$263K | 0.02% | 43 |
|
|
2013
Q4 | $1.54M | Sell |
30,190
-4,787
| -14% | -$240K | 0.02% | 45 |
|
|
2013
Q3 | $1.76M | Sell |
34,977
-7,600
| -18% | -$398K | 0.03% | 39 |
|
|
2013
Q2 | $2.09M | Buy |
+42,577
| New | +$2.32M | 0.03% | 38 |
|
Other funds holding LLY
Cornerstone Investment Partners's LLY Position: Q4 2021 in Review
Cornerstone Investment Partners sold out of Eli Lilly (LLY) in Q4 2021, closing a stake of 2,240 shares — an estimated $518K sold.
Cornerstone Investment Partners first reported a position in LLY in Q2 2013 and held it in 34 quarters. The position peaked at $2.31M in Q2 2021. 2,303 funds tracked by Wall St. Rank hold LLY as of Q4 2021.
- Cornerstone Investment Partners reported no remaining Eli Lilly position as of Q4 2021 after selling out during the quarter.
- Cornerstone Investment Partners sold 2,240 Eli Lilly shares in Q4 2021, an estimated $518K.
- Cornerstone Investment Partners first reported a position in Eli Lilly in Q2 2013 and held it in 34 quarters.
- Cornerstone Investment Partners's Eli Lilly position peaked at $2.31M in Q2 2021.
- 2,303 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.
Based on Cornerstone Investment Partners's 13F filing for Q4 2021, filed 7 Feb 2022.